|
SEEGENE is a biotechnology company specializing in molecular diagnostics, utilizing syndromic real-time PCR technology to detect multiple pathogens simultaneously from human and animal samples. The company develops and sells diagnostic reagents, automated diagnostic equipment, and data analysis software. Its product portfolio includes the Allplex series of multiplex PCR kits, the CURECA automated sample preparation system, and the STARlet-AIOS all-in-one PCR system. SEEGENE serves hospitals, clinical laboratories, and research institutions globally, with a presence in Europe, North America, and Asia through local subsidiaries and distributors. The company operates a technology-sharing initiative to collaborate with international partners on localized diagnostic solutions. Founded in 2000, SEEGENE holds patents in high-multiplex PCR technologies and maintains a global sales network. Summarised from the company's own disclosures, fiscal year ended May 2026 |
Industry Diagnostics & Research | Homepage kr.seegene.com |
| Sector Healthcare | IR page — | |
|
Tags
molecular diagnostics, pcr testing, infectious disease diagnostics, oncology diagnostics, automated laboratory systems, genetic testing, multiplex assays, clinical laboratory equipment, Allplex, CURECA, STARlet-AIOS, STAgora, SGDDS, SG OneSystem, Seegene viewer, SG STATS, DPO, TOCE, MuDT, 3Ct, STST, Werfen, Hylabs, Microsoft, Springer Nature
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | — |
| Market cap (USD) | — |
| P/E | — |
| PEG | — |
| P/BV | — |
| P/S | — |
| P/OCF | — |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 4.8% |
| ROI | 4.8% |
| ROIC | 2.9% |
| Profit margin | 10.2% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -35.8% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | — |
| Diluting (TTM) | — |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | — |
| Quality score | 27.3% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 474.232B | 414.252B | 367.375B | 853.561B | 1.371T | 1.125T | 121.953B | 102.265B | 87.663B | 73.694B | 65.137B | 64.411B | 58.993B |
| Net profit | 48.275B | -20.337B | 669.012M | 182.139B | 536.559B | 502.281B | 26.672B | 10.728B | 3.997B | 7.123B | 6.774B | 9.141B | 9.573B |
| Free cash flow | 111.977B | 45.397B | 69.778B | 255.746B | 272.368B | 209.129B | 23.076B | 11.079B | 14.51B | 10.658B | -6.317B | 4.138B | -4.133B |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (KRW) | 54.9B | 52.5B | 46.3B | 52.2B | 307B | 340B | 112B | 89.8B | 93.6B | 105B |
| ↳ YoY growth | -3.2% | -4.3% | -11.9% | +12.8% | +489.0% | +10.8% | -67.1% | -20.0% | +4.3% | +11.8% |
| ↳ 5y CAGR | -1.0% | +0.6% | +40.2% | +44.1% | +16.4% | +14.2% | +12.4% | -19.4% | ||
| Borrowings, current (KRW) | 678M | 6.96B | 8.43B | 6.42B | 37.9B | 40.8B | 80.5B | 75.9B | 75.8B | 76.1B |
| Borrowings, non-current (KRW) | 44.6B | 12.8B | 1.81B | 1.72B | 44.4B | 43.1B | 2.17B | 1.42B | 763M | 232M |
| Bonds payable (KRW) | 44.6B | 12B | — | — | — | — | — | — | — | — |
| Lease liabilities (KRW) | — | — | — | 6.96B | 20.7B | 75.1B | 76.5B | 64.5B | 67.1B | 53.6B |
| Cash and deposits (KRW) | 49.8B | 27.8B | 32.6B | 49.1B | 308B | 432B | 521B | 190B | 260B | 226B |
| Intangible assets (KRW) | 22.4B | 23.4B | 6B | 6.67B | 6.71B | 11.5B | 24.4B | 27.4B | 33B | 28.6B |
| Right-of-use assets (KRW) | — | — | — | 7.38B | 22.4B | 79.2B | 78.1B | 65.2B | 56.2B | 47.3B |
| Net debt (borrowings + leases - cash) (KRW) | -4.46B | -8.01B | -22.4B | -34B | -205B | -273B | -362B | -48.6B | -116B | -95.6B |
| Cash flow detail | ||||||||||
| Operating cash flow (KRW) | 16.6B | 19.3B | 14B | 27.1B | 383B | 334B | 319B | 94.9B | 85.4B | 149B |
| Purchases of property, plant and equipment (KRW) | -5.9B | -4.83B | -2.93B | -4.07B | -174B | -61.7B | -63.3B | -25.2B | -40B | -37.4B |
| Purchases of intangible assets (KRW) | -4.82B | -10.7B | -1.03B | -721M | -1.24B | -4.45B | -9.19B | -6.73B | -3.63B | -3.11B |
| Dividends paid (cash effect) (KRW) | — | — | — | — | -2.6B | -70B | -51.1B | -38.1B | -36.9B | -36.9B |
| Share buybacks (cash effect) (KRW) | 0.00 | -2.98B | — | — | — | -29.4B | -70.4B | -89.9B | -2.45B | -4.13B |
| Interest paid (cash effect) (KRW) | -511M | -348M | -357M | -386M | -1.61B | -1.76B | -2.88B | -3.79B | -3.42B | -4.4B |
| Income taxes paid (cash effect) (KRW) | -2.64B | -2.95B | 165M | 3.31B | -10.3B | -227B | -162B | -2.69B | -3.07B | 10.5B |
| Free cash flow (OCF - PPE - intangibles) (KRW) | 5.84B | 3.79B | 10B | 22.4B | 208B | 268B | 247B | 63.1B | 41.8B | 109B |
| Income detail | ||||||||||
| Research and development expense (KRW) | — | — | — | — | — | — | 94.7B | 72.7B | 69.4B | 66.3B |
| Total comprehensive income (KRW) | 6.73B | 2.76B | 10.3B | 26.6B | 496B | 536B | 188B | 5.53B | -16.6B | 59.5B |
| Comprehensive income to owners (KRW) | 6.68B | 2.71B | 10.3B | 26.5B | 495B | 535B | 188B | 5.34B | -16.7B | 59.4B |
| Reported | Nov 14, 2017 | Apr 2, 2018 | Nov 14, 2019 | Mar 30, 2020 | Mar 18, 2021 | Mar 14, 2024 | May 15, 2026 | Mar 19, 2026 | May 15, 2026 | Mar 19, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpDisclosures filed with DART (material events and exchange disclosures), newest first, headlines as filed in Korean. The link opens the filing on DART. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding SEEGENE
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVEE | 0.06% | 4,265 | $ 77.024K | Nov 16, 2026 |
| DFEV | 0.02% | 24,114 | $ 454.93K | Nov 12, 2026 |
| DEXC | 0.01% | 2,005 | $ 37.826K | Nov 12, 2026 |
| DFEM | 0.01% | 52,717 | $ 994.548K | Nov 12, 2026 |
| DFSE | 0.01% | 3,117 | $ 58.805K | Nov 12, 2026 |
| AVEM | 0.01% | 81,459 | $ 1.471M | Nov 16, 2026 |
| AVSE | 0.01% | 882 | $ 15.929K | Nov 16, 2026 |
| DFAE | 0.01% | 32,257 | $ 608.554K | Nov 12, 2026 |
| DFAX | 0.00% | 30,951 | $ 583.915K | Nov 12, 2026 |
| AVXC | 0.00% | 109 | $ 1,968.50 | Nov 16, 2026 |
